Imagen de Portada

Delphi Consensus on the Use of Fenofibrate as Systemic Therapy for the Prevention of Diabetic Retinopathy Progression

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Richard C. O'Brien, Khalifa Abdallah, Xuehong Dong, Mohamed Hassanein, Qiuhe Ji, Sakir Ozgur Keskek, Patricio Lopez‐Jaramillo, Roopa Mehta, Hussein Raef, Kevin Tan
Formato:	Artículo Open Access
Publicado:	Wiley 2026
Materias:	Journal of Diabetes
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

HMBG-1: A Biomarker in the Management of Diabetic Retinopathy
por: Burak Bilgin
Publicado: (2024)

Fenofibrate shown to reduce progression of diabetic retinopathy
por: Iskandar Idris
Publicado: (2024)

Rates, Risk Factors, and Progression of Diabetic Retinopathy in Children with Type 1 Diabetes: A 15‐Year Retrospective Study from a Regional Center in New Zealand
por: Thomas Winter, et al.
Publicado: (2024)

Role of Systemic Factors in the Progression to Vision‐Threatening Diabetic Retinopathy in a New Mexican Patient Population with Type 2 Diabetes: Glycemic Control Is Not Enough
por: Rushi N. Mankad, et al.
Publicado: (2026)

Risk Factors for Diabetic Retinopathy Change With Diabetes Duration: Synergistic Effect of Long Duration and Anemia
por: Yuan Liu, et al.
Publicado: (2026)

Cerebral Small Vessel Disease Outperforms Brain Atrophy as an Imaging Biomarker in Diabetic Retinopathy
por: Xinyi Shen, et al.
Publicado: (2025)

Assessment of Correlation Between Diabetic Retinopathy and Metabolic Biomarkers Using Artificial Intelligence
por: Mustafa Aydemir, et al.
Publicado: (2026)

Study on the Correlation Between GDF‐15 Levels and a Diagnostic Model for Diabetic Retinopathy
por: Xue-Nan Lian, et al.
Publicado: (2025)

Association of Albumin‐To‐Creatinine Ratio With Diabetic Retinopathy Among US Adults (NHANES 2009–2016)
por: Han Dai, et al.
Publicado: (2025)

A Study of the Relationship Between Serum Albumin–Corrected Fructosamine and Type 2 Diabetic Retinopathy
por: Zejiang Liu, et al.
Publicado: (2026)

Identification of Risk Factors for the Development of Diabetic Retinopathy Among Palestinian Adults With Type 2 Diabetes Mellitus: A Cross‐Sectional Study
por: Oadi N. Shrateh, et al.
Publicado: (2024)

Diabetic Retinopathy and Cognitive Dysfunction in Type 2 Diabetes Mellitus: A Systematic Review and Meta‐Analysis of Epidemiological Associations and Clinical Implications
por: Ye He, et al.
Publicado: (2026)

Association of SGLT2 Inhibitor With Stroke in Type 2 Diabetes With Diabetic Retinopathy: A Multicenter Electronic Health Record Data Study
por: Kuo‐En Chen, et al.
Publicado: (2026)

Cost‐Effectiveness of Artificial Intelligence Assisted Screening for Diabetic Retinopathy: A Markov Model
por: Chia‐Fen Wang, et al.
Publicado: (2026)

Preoperative Intravitreal Conbercept Injection Reduced Both Angiogenic and Inflammatory Cytokines in Patients With Proliferative Diabetic Retinopathy
por: Zijing Huang, et al.
Publicado: (2024)

Associations Between Serum IL‐17A, Renal Function and Diabetic Retinopathy in Type 2 Diabetes Mellitus: Evidence From a Chinese Han Population
por: Wensu Wang, et al.
Publicado: (2025)

Qinggan Mingshi Granules Inhibited Ferroptosis to Treat Diabetic Retinopathy in Mice Through NRF2/GPX4 Axis
por: Zhongyong Zhang, et al.
Publicado: (2026)

Continuous Glucose Monitoring–Enhanced eConsult Improves Clinical Outcomes in Adults Living With Diabetes in a Safety Net Primary Care Setting
por: Samantha M. Siskind, et al.
Publicado: (2025)

What Is the Role of AI in Diabetic Retinopathy Screening?
por: Rasit Dinc
Publicado: (2017)

ABHD1 Facilitates Intermediate Filament–Mediated Endothelial Cell Chemotaxis by Regulating KRT1 and KRT2 in Diabetic Retinopathy
por: Xinyi Liu, et al.
Publicado: (2024)

Corrigendum to “ISPAD Clinical Practice Consensus Guidelines 2022: Type 2 Diabetes in Children and Adolescents”
Publicado: (2025)

Are We Ready With Prevention for Type 1 Diabetes?
por: Evelina Maines, et al.
Publicado: (2025)

Application and Progression of Single‐Cell RNA Sequencing in Diabetes Mellitus and Diabetes Complications
por: Jiajing Hong, et al.
Publicado: (2025)

Preventing and Managing Vascular Complications in Adolescents With Type 1 Diabetes
por: Beatrice Prampolini, et al.
Publicado: (2025)

Comment on: “Prevalence and Influencing Factors of Malnutrition in Diabetic Patients: A Systematic Review and Meta‐Analysis”
por: Shubham Kumar, et al.
Publicado: (2025)

Awareness Campaigns to Prevent Diabetic Ketoacidosis at Diabetes Onset Are Successful When Constantly Maintained: From Local to Federal State Results
por: Martin Holder, et al.
Publicado: (2025)

Challenging the Consensus Statement: Is It Time to Recognise Pharmacological Remission of Type 2 Diabetes?
por: Cristina Bianchi, et al.
Publicado: (2026)

Comment on “Time Trends in Cardiovascular Event Incidence in New‐Onset Type 2 Diabetes: A Population‐Based Cohort Study From Germany”
por: Saraswati Sah, et al.
Publicado: (2025)

Clinical Significance of Conjunctival Microvascular Density in Diabetic Retinopathy: A Multimodal Correlation Study Based on Swept‐Source Optical Coherence Tomography Angiography
por: Xiaoli Huang, et al.
Publicado: (2026)

Exploring Vitamin D Signaling‐Associated Biomarkers and Their Diagnostic Value in Diabetic Retinopathy: A Combined Transcriptomic and Single‐Cell Analysis With Experimental Validation
por: Pengfei Chen, et al.
Publicado: (2026)

Impaired Cardiorespiratory Fitness in Type 1 Diabetes Is Associated With Metabolic Inflexibility and Specific Factors According to Sex
por: Liliana Muñoz‐Hernandez, et al.
Publicado: (2025)

The Role of Negative Pressure Therapy in Diabetic Foot Ulcer: A Meta‐Analysis
por: Hai Du, et al.
Publicado: (2026)

Longitudinal Trajectories of Albuminuria and eGFR in Type 2 Diabetes Mellitus: Natural Progression of Diabetic Kidney Disease
por: Xiuqi Qiao, et al.
Publicado: (2025)

Updates in Type 1 Diabetes ( T1D ): What Recent Findings Might Mean for Treatment and Prevention Strategies
por: Zachary Bloomgarden
Publicado: (2026)

Targeting SIRT3 to Ameliorate Diabetic Cardiomyopathy: Progress in Mechanistic Research and Prospects for Clinical Translation
por: Yuting Lin, et al.
Publicado: (2025)

American Diabetes Association complete guide to diabetes / American Diabetes Association
por: American Diabetes Association
Publicado: (2011)

Risk Factors for the Progression or Regression to Diabetes or Normoglycaemia for Men with Impaired Fasting Glucose
por: Jacob W. Harland, et al.
Publicado: (2025)

Recommendations for the Management of Diabetes During Ramadan Applying the Principles of the ADA/ EASD Consensus: Update 2025
por: Mahmoud Ibrahim, et al.
Publicado: (2025)

Reply to “A comment on ‘Metformin in the Diabetes Prevention Program 3‐year trial: The cost‐effectiveness that never was’”
por: Brian Eric Rittenhouse, et al.
Publicado: (2025)

The Role of Bicarbonate Therapy in Diabetic Ketoacidosis: A Systematic Review and Meta‐Analysis
por: Abu Omayer, et al.
Publicado: (2026)